Mostrar el registro sencillo del ítem
dc.contributor.author | Linertová, Renata | |
dc.contributor.author | Valcárcel-Nazco, Cristina | |
dc.contributor.author | Posada De la Paz, Manuel | |
dc.contributor.author | López-Bastida, Julio | |
dc.contributor.author | Serrano-Aguilar, Pedro | |
dc.contributor.author | BURQOL-RD Research Network | |
dc.date.accessioned | 2023-03-07T11:52:53Z | |
dc.date.available | 2023-03-07T11:52:53Z | |
dc.date.issued | 2016 | |
dc.identifier.citation | Rare Dis Orphan Drugs. 2016, 3 (1): 5-10. | es_ES |
dc.identifier.issn | 2284-2543 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/15579 | |
dc.description.abstract | Most of rare diseases lead to a certain level of disability. In Spain, disabled persons receive long-time benefits, but only if they possess a disability evaluation that officially certifies the degree of their disability. Sometimes, the affected persons can experience disagreement with the obtained evaluation. Our aim was to analyse the level of agreement among rare disease patients and caregivers in Spain with their official disability evaluation and its possible relationship with their health-related quality of life (HRQoL) and the general satisfaction with the national healthcare system (NHS). Data were collected from patients (n = 123) and caregivers (n = 74) as a part of BURQOL-RD Project that measured the burden of ten rare diseases in Europe. HRQoL was evaluated by the generic instrument EQ-5D. Satisfaction with NHS was measured on a scale from 1 to 10. Almost 30% of respondents did not agree with their disability evaluation. These persons expressed less satisfaction with NHS than those who were in accord with their evaluation (5.1 vs 6.8; p <0.0001). Patients’ and caregivers’ HRQoL was also worse for the disagreement group, but did not reach a statistical significance. Correctly evaluated degree of disability is fundamental and has many consequences for all affected parties. Disability evaluation rules should reflect the specificities of rare diseases. | es_ES |
dc.description.sponsorship | This publication arises from the project “Social economic burden and health-related quality of life in patients with rare diseases in Europe (BURQOLRD)” which has received funding from the European Union in the framework of the Health Programme (Grant number A101205). The Executive Agency of the European Union is not responsible for any use that may be made of the information contained herein | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Istituto Superiore di Sanità (ISS) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Disability | es_ES |
dc.subject | Rare diseases | es_ES |
dc.subject | Benefits | es_ES |
dc.subject | Satisfaction | es_ES |
dc.subject | Health-related quality of life | es_ES |
dc.title | Disability evaluation in patients with rare diseases in Spain: the importance of being in accord. BURQOL-RD Project | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.format.volume | 3 | es_ES |
dc.format.number | 1 | es_ES |
dc.format.page | 5-10 | es_ES |
dc.contributor.funder | Unión Europea | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 2385-2364 | es_ES |
dc.relation.publisherversion | http://www.rarejournal.org/index.php/rarejournal/article/view/86 | es_ES |
dc.identifier.journal | Rare Diseases and Orphan Drugs Journal | es_ES |
dc.repisalud.centro | ISCIII::Instituto de Investigación de Enfermedades Raras | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.relation.projectID | info:eu-repo/grantAgreement/EC/A101205/EU | es_ES |
dc.rights.accessRights | open access | es_ES |